US 11246859
Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers
granted A61KA61K31/4439A61K31/506
Quick answer
US patent 11246859 (Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers) held by Biomed Valley Discoveries, Inc. expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Biomed Valley Discoveries, Inc.
- Grant date
- Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/4439, A61K31/506, A61K31/519, A61K45/06